434
edits
Clinical Research and Clinical Trial Professional and Technical Fee Billing: Difference between revisions
Clinical Research and Clinical Trial Professional and Technical Fee Billing (view source)
Revision as of 14:06, August 2, 2023
, August 2, 2023→Additional Information
Mhurlocker (talk | contribs) |
Mhurlocker (talk | contribs) |
||
| Line 50: | Line 50: | ||
Patient care costs arising from services performed solely for research purposes are charged to the study. Research-only items and services are not billable to patients or third parties. | Patient care costs arising from services performed solely for research purposes are charged to the study. Research-only items and services are not billable to patients or third parties. | ||
==Additional Information== | ==Additional Information== | ||
*Contact the [[ | *Contact the [[Mailto:sarah.glodencarlson@unmc.edu|Chief Compliance Officer]] | ||
*Nebraska Medicine Policy MI19, [https://secure.compliance360.com/Common/ViewUploadedFile.aspx?PD=PbRt%2bA78MS76r98JrMX%2fsnAPT69slLD9yT9uy7BKwroGpDduZ0TU6MF%2bvIKJqdzaOI%2be219RNS0yx9K7goLYfG18l5M2OOq%2f6qTckWuxdgRREjJRXpJG57qCC1zFErD5mNQ3fzQLZyJcE4r6VLn%2b9NZ5%2foRW5T2zXXvwRKhGwzUy4xoDZdMJo9lOLsVQYVhtbYHPJ6sv5fXe%2fP3CnOaUQzybxHnKE%2biL5NfGDN1WHaT3sR%2bVZgjoZ6p6kt2pDtyoQ3Igzxa%2f9Sy5yZSvEVI91Q%3d%3d Research Billing Process policy] | *Nebraska Medicine Policy MI19, [https://secure.compliance360.com/Common/ViewUploadedFile.aspx?PD=PbRt%2bA78MS76r98JrMX%2fsnAPT69slLD9yT9uy7BKwroGpDduZ0TU6MF%2bvIKJqdzaOI%2be219RNS0yx9K7goLYfG18l5M2OOq%2f6qTckWuxdgRREjJRXpJG57qCC1zFErD5mNQ3fzQLZyJcE4r6VLn%2b9NZ5%2foRW5T2zXXvwRKhGwzUy4xoDZdMJo9lOLsVQYVhtbYHPJ6sv5fXe%2fP3CnOaUQzybxHnKE%2biL5NfGDN1WHaT3sR%2bVZgjoZ6p6kt2pDtyoQ3Igzxa%2f9Sy5yZSvEVI91Q%3d%3d Research Billing Process policy] | ||
*Nebraska Medicine IM41, [https://secure.compliance360.com/Common/ViewUploadedFile.aspx?PD=PbRt%2bA78MS7eVp6GSyceIKy%2bKyb5RrkCW2YkeH1EjEezWPeZSoR8aA44LtQlerPEaAvfAdpaDQbnqcu7z6csMxCvKp%2b9Bo6M6JRvPOAMe7Q831n2bXuS2Wtk%2b9L9Z3wo%2fEwS7Bh9T%2bxm9ey2RMka3yd1HdRU1wxR9mXS6fFTlBL%2f4YZH1mTmOQ%2bulEgXr90HEFrimbXy7yGSxk4lf7%2bb7Gu9wYychcd9R6f%2fYJ6fONrwVJRRQdzIHEwqK%2fDdjbDTVJlTiwGUC8aQ8QAuWc9Zvg%3d%3d One Chart Research Documentation] | *Nebraska Medicine IM41, [https://secure.compliance360.com/Common/ViewUploadedFile.aspx?PD=PbRt%2bA78MS7eVp6GSyceIKy%2bKyb5RrkCW2YkeH1EjEezWPeZSoR8aA44LtQlerPEaAvfAdpaDQbnqcu7z6csMxCvKp%2b9Bo6M6JRvPOAMe7Q831n2bXuS2Wtk%2b9L9Z3wo%2fEwS7Bh9T%2bxm9ey2RMka3yd1HdRU1wxR9mXS6fFTlBL%2f4YZH1mTmOQ%2bulEgXr90HEFrimbXy7yGSxk4lf7%2bb7Gu9wYychcd9R6f%2fYJ6fONrwVJRRQdzIHEwqK%2fDdjbDTVJlTiwGUC8aQ8QAuWc9Zvg%3d%3d One Chart Research Documentation] | ||